Trans American Aquaculture (GRPS) Liabilities and Shareholders Equity (2022 - 2025)

Trans American Aquaculture (GRPS) reported Liabilities and Shareholders Equity of $1.1 million for Q3 2025, down 85.42% on a YoY basis from $7.6 million in Q3 2024, and up 2.42% quarter-over-quarter from $1.1 million in Q2 2025.

Trans American Aquaculture (GRPS) Liabilities and Shareholders Equity (2022 - 2025) Analysis & Trends

Trans American Aquaculture has reported Liabilities and Shareholders Equity for 4 years, with the latest figure at $1.1 million in Q3 2025.

  • For the quarter ending Q3 2025, Liabilities and Shareholders Equity fell 85.42% year-over-year to $1.1 million; the trailing twelve-month figure through Sep 2025 stood at $4.1 million (down 86.57% YoY), and the FY2024 full-year result was $948015.0, down 87.63% from the prior year.
  • Liabilities and Shareholders Equity for Q3 2025 stood at $1.1 million, up from $1.1 million in the prior quarter.
  • The five-year high for Liabilities and Shareholders Equity was $7.8 million in Q1 2023, with the low at $948015.0 in Q4 2024.
  • Historically, Liabilities and Shareholders Equity has averaged $5.0 million across 4 years, with a median of $7.6 million in 2023.
  • Annual changes were most pronounced in 2023 — Liabilities and Shareholders Equity slipped 0.11% — and 2024, when it tumbled 87.63%.
  • Trans American Aquaculture's Liabilities and Shareholders Equity stood at $7.7 million in 2022, then retreated by 0.11% to $7.7 million in 2023, then plunged by 87.63% to $948015.0 in 2024, then climbed by 16.74% to $1.1 million in 2025.
  • The last three Liabilities and Shareholders Equity figures came in at $1.1 million (Q3 2025), $1.1 million (Q2 2025), and $988748.0 (Q1 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 40.04 Bn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 15.15 Bn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 6.71 Bn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn 555.95 Mn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 4.91 Bn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 13.22 Bn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn 4.26 Bn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn 2.27 Bn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 2.35 Bn
10 Trans American Aquaculture - - - 1.11 Mn

Historic Data

Download Data
DateValue
Sep 30, 2025 1.11 Mn
Jun 30, 2025 1.08 Mn
Mar 31, 2025 988,748.00
Dec 31, 2024 948,015.00
Sep 30, 2024 7.59 Mn
Jun 30, 2024 7.79 Mn
Mar 31, 2024 7.67 Mn
Dec 31, 2023 7.66 Mn
Mar 31, 2023 7.84 Mn
Dec 31, 2022 7.67 Mn